Black Rock Inc. Legend Biotech Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,721,277 shares of LEGN stock, worth $212 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,721,277
Previous 5,384,030
6.26%
Holding current value
$212 Million
Previous $302 Million
16.09%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
71.1MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$256 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$249 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million6.23% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$139 Million5.57% of portfolio
-
Braidwell LP Stamford, CT2.98MShares$110 Million6.2% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...